AQUINOX PHARMACEUTICALS INC — Form D

AQUINOX PHARMACEUTICALS INC of RICHMOND, A1, a company, filed a Form D exempt-offering notice with the SEC on 2010-04-16. The offering totals $9, of which $9 was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
David MainDirectorVancouver, A1
David MainExecutive OfficerVancouver, A1
Kenneth GalbraithDirectorVancouver, A1
Dr. Asish XavierDirectorRichmond, A1
Dr. Daniel LevinDirectorRichmond, A1
Dr. Thomas MacRuryExecutive OfficerRichmond, A1
Dr. Elain JonesDirectorRichmond, A1
Kamran AlamExecutive OfficerRichmond, A1
Dr. Elaine J JonesDirectorRichmond, A1
Dr. Asish J XavierDirectorRichmond, A1
Frank J HollerDirectorRichmond, A1
Kamran J AlamExecutive OfficerRichmond, A1
Kenneth J GalbraithDirectorRichmond, A1
David J MainDirectorRichmond, A1
David J MainExecutive OfficerRichmond, A1
David J MainPromoterRichmond, A1
Dr. Thomas J MacRuryExecutive OfficerRichmond, A1
Dr. Daniel J LevittDirectorRichmond, A1
Frank H HollerDirectorVancouver, A1
Kenneth H GalbraithDirectorVancouver, A1
Elaine H JonesDirectorNew York, NY
Csaba H SzaboExecutive OfficerRichmond, A1
Asish H XavierDirectorNew Brunswick, NJ
Daniel H LevittDirectorRichmond, A1
David H ChernoffExecutive OfficerRichmond, A1

Other filings by this issuer (4)

FiledFormOfferingSold
2013-04-02D$39$26
2011-09-26D$6$6
2011-02-11D$9$9
2010-06-25D$6$6

More